How inflammation changes bone-building cells and bone repair
Mechanisms of inflammatory osteoblastogenesis and bone formation
This work looks at whether turning down an overactive interferon-related signal in bone-forming cells can help people with inflammatory bone loss, such as rheumatoid arthritis, rebuild bone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hospital for Special Surgery NIH-funded |
| Lab location | 1 site (New York, UNITED STATES) |
| Project ID | NIH-11237128 on NIH RePORTER |
What this research studies
You should know that inflammation can cause too much bone breakdown while blocking the cells that normally make new bone. The researchers discovered that bone-forming cells carry a constant type I interferon signal and that a gene called Eif2ak2 appears to limit bone formation. In the lab they will use cultured bone cells and animal models to see how this interferon response and Eif2ak2 control osteoblast development and bone repair. The goal is to find molecular targets that could be used later to help restore bone formation in inflammatory conditions.
Who could benefit from this research
Good fit: Adults with inflammatory bone-loss conditions (for example rheumatoid arthritis or severe periodontitis) would be the most relevant group for future clinical work stemming from this research.
Not a fit: People whose bone loss is primarily non-inflammatory (for example age-related osteoporosis without inflammatory disease) or children under 21 are less likely to benefit from these findings.
Why it matters
Potential benefit: If successful, this work could point to new ways to restore bone formation for people with inflammatory bone loss like rheumatoid arthritis or severe periodontitis.
How similar studies have performed: Early laboratory data identified an interferon signature in osteoblasts and flagged Eif2ak2 as an inhibitor, but applying this approach to boost bone formation in patients is largely new and untested clinically.
Where this research is happening
New York, UNITED STATES
- Hospital for Special Surgery — New York, United States (Active)
Researchers
- Principal investigator: Zhao, Baohong — Hospital for Special Surgery
- Study coordinator: Zhao, Baohong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.